Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Biocryst Pharmaceuticals Inc (BCRX)  
$6.31 0.13 (2.02%) as of 4:30 Fri 6/7


Download
   
Exchange: Nasdaq National Market
Security Type: Common
Shares Out: 189,490,000
Market Cap: 1.20(B)
Last Volume: 3,291,159 Avg Vol: 4,448,162
52 Week Range: $4.13 - $8.81
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Biotechnology

Member Indexes:
    NASDAQ BIOTECHNOLOGY     NASDAQ COMPOSITE
    NASDAQ NNM COMPOSITE

Rankings:
     
Insider 3 Months    : 16.9
Insider 6 Months    : 16.9
Insider 3/6 Months : 32.4
Guru Rank Number :  455
Guru Rank Value     : 3
Guru Occurances    : 1

 

            6 Months   1 Year   2 Year  
 
Company Profile   BioCryst Pharmaceuticals is a commercial-stage biotechnology company that discovers oral, small-molecule medicines. Co. focuses on oral treatments for rare diseases. Co.'s drug/drug candidates include: ORLADEYO™ (berotralstat), an oral serine protease inhibitor targeting kallikrein that is being developed for the prevention of Hereditary Angioedema attacks; BCX9930, an oral factor D inhibitor for the treatment of complement-mediated diseases; BCX9250, an oral activin receptor-like kinase-2 inhibitors for the treatment of fibrodysplasia ossificans progressive; and RAPIVAB® (peramivir injection), an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 183,601 183,601 183,601 183,601
Total Buy Value $1,048,338 $1,048,338 $1,048,338 $1,048,338
Total People Bought 10 10 10 10
Total Buy Transactions 10 10 10 10
Total Shares Sold 0 0 16,866 495,199
Total Sell Value $0 $0 $135,363 $5,999,241
Total People Sold 0 0 2 9
Total Sell Transactions 0 0 2 14
End Date 2024-03-10 2023-12-08 2023-06-09 2022-06-09

   
Records found: 475
  Page 11 of 19  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Staab Thomas R Ii Senior Vice President and CFO   •       •      –    2018-11-21 4 AS $9.08 $110,610 D/D (12,000) 137,383     -
   Staab Thomas R Ii Senior Vice President and CFO   •       •      –    2018-11-21 4 OE $3.78 $53,710 D/D 12,000 144,383     -
   Powell Lynne Senior VP - CCO   •       •      –    2018-11-21 4 AS $9.01 $130,840 D/D (14,455) 0     -
   Powell Lynne Senior VP - CCO   •       •      –    2018-11-21 4 OE $3.22 $38,640 D/D 12,000 14,455     -
   Powell Lynne Senior VP - CCO   •       •      –    2018-11-20 4 AS $8.52 $130,714 D/D (15,277) 2,455     -
   Powell Lynne Senior VP - CCO   •       •      –    2018-11-20 4 OE $3.22 $29,389 D/D 9,127 17,732     -
   Staab Thomas R Ii Senior Vice President and CFO   •       •      –    2018-11-20 4 AS $8.57 $96,494 D/D (11,123) 137,383     -
   Staab Thomas R Ii Senior Vice President and CFO   •       •      –    2018-11-20 4 OE $3.22 $38,405 D/D 11,123 143,883     -
   Powell Lynne Senior VP - CCO   •       •      –    2018-11-19 4 AS $8.30 $1,602 D/D (193) 8,605     -
   Powell Lynne Senior VP - CCO   •       •      –    2018-11-19 4 OE $3.22 $621 D/D 193 8,798     -
   Staab Thomas R Ii Senior Vice President and CFO   •       •      –    2018-11-19 4 AS $8.30 $623 D/D (75) 137,383     -
   Staab Thomas R Ii Senior Vice President and CFO   •       •      –    2018-11-19 4 OE $3.78 $284 D/D 75 137,458     -
   Powell Lynne Senior VP - CCO   •       •      –    2018-11-08 4 AS $8.15 $43,032 D/D (5,280) 8,605     -
   Powell Lynne Senior VP - CCO   •       •      –    2018-11-08 4 OE $3.22 $17,002 D/D 5,280 13,885     -
   Staab Thomas R Ii Senior Vice President and CFO   •       •      –    2018-11-08 4 AS $8.09 $109,011 D/D (13,415) 137,383     -
   Staab Thomas R Ii Senior Vice President and CFO   •       •      –    2018-11-08 4 OE $3.22 $44,485 D/D 13,415 139,685     -
   Powell Lynne Senior VP - CCO   •       •      –    2018-11-07 4 AS $8.00 $2,400 D/D (300) 8,605     -
   Powell Lynne Senior VP - CCO   •       •      –    2018-11-07 4 OE $3.22 $966 D/D 300 8,905     -
   Staab Thomas R Ii Senior Vice President and CFO   •       •      –    2018-11-07 4 AS $8.00 $5,376 D/D (672) 137,383     -
   Staab Thomas R Ii Senior Vice President and CFO   •       •      –    2018-11-07 4 OE $3.22 $2,164 D/D 672 138,055     -
   Staab Thomas R Ii Senior Vice President and CFO   •       •      –    2018-11-05 4 AS $8.00 $1,720 D/D (215) 137,383     -
   Staab Thomas R Ii Senior Vice President and CFO   •       •      –    2018-11-05 4 OE $3.22 $692 D/D 215 137,598     -
   Powell Lynne Senior VP - CCO   •       •      –    2018-11-05 4 AS $8.00 $800 D/D (100) 8,605     -
   Powell Lynne Senior VP - CCO   •       •      –    2018-11-05 4 OE $3.22 $322 D/D 100 8,705     -
   Staab Thomas R Ii Senior Vice President and CFO   •       •      –    2018-11-02 4 AS $7.78 $85,090 D/D (10,856) 137,383     -
  475 Records found
  Previous  10  11  12  13  14  15  16  17  18  19   
  Page 11 of 19
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us